Method, composition and device for sampling natriuretic peptides in biological fluid
WO2008024391A1
Pharmaceutical formulations of an indole-type derivative and related methods of use
WO2007047614A2
Glycosylated probnp
WO2007041645A2
Oxidized human bnp
WO2008079105A1
Methods to synthesize indoles as precursors for pharmaceuticals
US2007066833A1
Methods to synthesize indoles as precursors for pharmaceuticals
WO2007005863A1
Crystalline forms of (2r-trans)-6-chloro-5[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n, 1-trimethyl-alpha-oxo-1h-indole-3-acetamide monohydrochloride
US2007066632A1
Fused bicyclic inhibitors of TGFbeta
US2006258582A1
Method of treating myelodysplastic syndromes
WO2006026663A1
Methods for treating congestive heart failure
US2006052390A1
Treatment of multiple myeloma by p38 MAP kinase and proteasome inhibition
US2006058296A1
Treatment of osteolytic lesions associated with multiple myeloma by inhibition of p38 map kinase
US2006079461A1
Treatment of multiple myeloma by inhibition of p38 MAP kinase
WO2006112828A1
Azaindole derivatives as inhibitors of p38 kinase
EP1720562A1
Method for treating cardiac remodeling following myocardial injury
US7119199B2
Process for the preparation of pyridopyrimidones
BRPI0417213A
treatment of malignant gliomas with tgf-beta inhibitors
WO2005032551A1
TREATMENT OF CARDIOVASCULAR DISEASE WITH INHIBITORS OF p38 KINASE
US7244441B2
Stents and intra-luminal prostheses containing map kinase inhibitors
